Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,772 signal articles · 73 in last 24h · 148,324 total before filter · latest 1h ago
73last 24h
976last 7d
109● bullish (7d)
126● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst11
✕ clear all filtersticker: PLTRSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Did You Pay For Palantir's Guidance Or For Something Else?
Trefis4d agoneutral
Did You Pay For Palantir's Guidance Or For Something Else?

Palantir Technologies (PLTR) raised its 2026 revenue guidance in August, and the stock gained about 32% across the release. The easy read is that the market was paying for the bigger number. It was not. At the multiple the market was already paying, that raise is worth about $8 a share, and the tape handed over close to $40.

Palantir (PLTR) Stock Fair Value Edges Higher After Strong Q2 And Raised Guidance
Simply Wall St.14d agoneutral
Palantir (PLTR) Stock Fair Value Edges Higher After Strong Q2 And Raised Guidance

Palantir Technologies is back in focus as fresh research lifts fair value estimates from US$185.70 to US$191.68, while price targets in recent reports cluster in a higher US$200 to US$245 range. Analysts are updating these targets after what they describe as an exceptional Q2 2026 report, stronger AI related demand, and new guidance that has split opinion on how much upside is still left. Read on to see how this evolving narrative could shape the way you think about Palantir Technologies from...

3 Software Stocks Recently Raising Guidance
Zacks22d agoneutral
3 Software Stocks Recently Raising Guidance

Guidance upgrades are generally one of the most bullish things to watch for in earnings season, as renewed outlooks can often lead to positive EPS revisions, one of the strongest drivers of a stock's near-term movement.

How Pentagon Maven Deal And Raised Guidance At Palantir Technologies (PLTR) Has Changed Its Investment Story
Simply Wall St.23d agoneutral
How Pentagon Maven Deal And Raised Guidance At Palantir Technologies (PLTR) Has Changed Its Investment Story

In recent weeks, Palantir Technologies reported stronger-than-expected quarterly results, raised its full-year revenue guidance, and saw its Maven Smart System formally designated as a Pentagon program of record, supporting up to US$2.30 billion in funding over five years. These developments, alongside active trading by high-profile investors and insiders and generally positive analyst sentiment, highlight how Palantir’s AI-driven government and commercial platforms are becoming more...

Q2 Earnings Season Standout Performers: PLTR, MSFT
Zacks32d agoneutral
Q2 Earnings Season Standout Performers: PLTR, MSFT

The Q2 earnings season continues to wind down, which has overall shown immense strength with outsized growth. There have been several standout releases during the Q2 earnings cycle, including those from Palantir (PLTR) and Microsoft (MSFT).

Palantir Technologies (PLTR) Is Up 8.0% After Raising 2026 Revenue Guidance On Stronger Q2 Results
Simply Wall St.37d agoneutral
Palantir Technologies (PLTR) Is Up 8.0% After Raising 2026 Revenue Guidance On Stronger Q2 Results

In early August 2026, Palantir Technologies reported second-quarter results showing sales of US$1.94 billion and net income of US$1.06 billion, alongside stronger performance for the first half of the year and higher earnings per share than a year earlier. Management also raised full-year 2026 revenue guidance to between US$8.15–US$8.16 billion and reiterated expectations for GAAP profitability each quarter, underscoring confidence that demand for its AI platforms will support continued...

Inovio Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat37d agoneutral
Inovio Pharmaceuticals Q2 Earnings Call Highlights

Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration has completed several key steps in its review of the company’s biologics license application for INO-3107, an investigational treatment for recurrent respiratory papillomatosis, or RRP, while the company continues prepara

Zeta Global’s Q2 Earnings Call: Our Top 5 Analyst Questions
StockStory37d agoneutral
Zeta Global’s Q2 Earnings Call: Our Top 5 Analyst Questions

Zeta Global's second quarter saw robust top-line growth, surpassing Wall Street’s revenue and profit expectations. Despite this, the market reacted negatively following the results. Management attributed the strong quarter to accelerated adoption of Zeta’s AI-powered Athena platform and deeper cross-industry partnerships, particularly with OpenAI, Palantir, and Snowflake. CEO David Steinberg emphasized that “Athena is fundamentally changing how customers interact with the Zeta platform,” highlig

Palantir Technologies’s Q2 Earnings Call: Our Top 5 Analyst Questions
StockStory38d agoneutral
Palantir Technologies’s Q2 Earnings Call: Our Top 5 Analyst Questions

Palantir Technologies delivered Q2 results that notably surpassed Wall Street expectations, leading to a significant positive market reaction. Management credited surging demand for its artificial intelligence (AI) platform, especially in the U.S. commercial and government sectors, as the primary driver of the quarter’s performance. CEO Alexander Karp emphasized that the company’s “forward deployed engineering model” and focus on customer-specific solutions were key in translating AI advancement

Vitalhub Q2 Earnings Call Highlights
MarketBeat40d agoneutral
Vitalhub Q2 Earnings Call Highlights

Vitalhub (TSE:VHI) reported second-quarter 2026 revenue of CAD 31.7 million, up 33% from the prior-year period, while annual recurring revenue surpassed CAD 100 million for the first time. Chief Financial Officer Brian Goffenberg said the company ended June with CAD 101.5 million in annual recurrin

Zeta Global Q2 Earnings Call Highlights
MarketBeat40d agoneutral
Zeta Global Q2 Earnings Call Highlights

Zeta Global (NYSE:ZETA) reported second-quarter 2026 revenue of $443 million, up 44% from a year earlier, or 28% excluding revenue from mergers and acquisitions. The company said the result marked its 20th consecutive quarter of beating and raising its outlook. Adjusted EBITDA rose 56% year over ye

USA Today Q2 Earnings Call Highlights
MarketBeat41d agoneutral
USA Today Q2 Earnings Call Highlights

USA Today (NYSE:TDAY) reported second-quarter 2026 revenue of $536.3 million, down 8.3% from a year earlier, as lower digital advertising revenue and quarter-to-quarter variability in content licensing offset gains in digital-only subscriptions and other digital revenue streams. The company generat

Jim Cramer’s Post Earnings Palantir Technologies Inc. (NASDAQ:PLTR) Worry Didn’t Materialize
Insider Monkey42d agoneutral
Jim Cramer’s Post Earnings Palantir Technologies Inc. (NASDAQ:PLTR) Worry Didn’t Materialize

Palantir Technologies Inc. (NASDAQ:PLTR) is a stock that Jim Cramer has, perhaps begrudgingly, shifted his opinion on. Throughout 2025, the CNBC TV was nothing short of unbridled optimism for the firm. Cramer asserted on multiple occasions that Palantir Technologies Inc. (NASDAQ:PLTR) was slated to benefit from the Trump administration’s focus on cost-cutting and its ability […]